ACM Research, Inc. (ACMR) SEC Filings & Earnings Calls
EquiReason read 27 ACM Research, Inc. SEC filings in the last 12 months. Latest: 8-K on 2026-09-30 — ACM Research subsidiary provides backlog data via press release;.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
- Market cap
- 3.5B
- P/E TTM
- 24.1
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 5 Nov, in 12 days
Every filing, read
last 12 months · SECWhat happened, the numbers inside, guidance and risks. The original is one click away.
7 Aug 202610-QRevenue $524M (+35% y/y); Net Income $148M (+142% y/y); Adjusted EBITDA $114M (+33% y/y)open
Figures in the filing · each found in the filing text
| Revenue · H1 2026 | $524M | +35% y/y |
| Net Income · H1 2026 | $148M | +142% y/y |
| Adjusted EBITDA · H1 2026 | $114M | +33% y/y |
| Shipments · H1 2026 | $522M | +44% y/y |
| Repeat Tool Shipments · H1 2026 | $266M | +59% y/y |
| First Tool Shipments · H1 2026 | $256M | +31% y/y |
| Gross Profit · H1 2026 | $242M | +29% y/y |
| Free Cash Flow · H1 2026 | $-128M | -80% y/y |
| Operating Cash Flow · H1 2026 | $-36M | -9% y/y |
Risks flagged
China Concentration Risk
“To date, substantially all of our sales of equipment for semiconductor-manufacturing have been to customers located in Asia, and we anticipate that a substantial majority of our revenue from these products will continue to come from customers located in this region for the foreseeable future.” · word for word
First Tool Acceptance Risk
“First tool shipments can be made to either an existing customer that has not previously accepted that specific type of tool in the past ... customers have significant, or in some cases total, discretion in determining whether to accept or purchase our tools after evaluation” · word for word
Negative Free Cash Flow
“Free cash flow $ (127,905) $ (71,077) 80.0 %” · word for word
7 Aug 20268-K · 2.02Revenue $293M (+36% y/y); Gross Margin (GAAP) 46; Income from Operations (GAAP) $50M; Guidance: Raised FY2026 revenue guidance to $1.125B-$1.175B from $1.08B-$1.175B (midpoint raised ~$50M)earningsopen
Figures in the filing · each found in the filing text
| Revenue · Q2-2026 | $293M | +36% y/y |
| Gross Margin (GAAP) · Q2-2026 | 46.0% | |
| Income from Operations (GAAP) · Q2-2026 | $50M | |
| Net Income Attributable to ACM Research (GAAP) · Q2-2026 | $89M | |
| Diluted EPS (GAAP) · Q2-2026 | $1.23 | |
| Non-GAAP Diluted EPS · Q2-2026 | $0.61 | |
| Total Shipments · Q2-2026 | $282M | +36% y/y |
Guidance
Raised FY2026 revenue guidance to $1.125B-$1.175B from $1.08B-$1.175B (midpoint raised ~$50M)
ACM Research raised full-year 2026 revenue guidance due to strong Q2 results, new product cycles, and market share gains.
Risks flagged
International trade policy and supply chain constraints could impact future performance.
“This expectation is based on ACM management’s current assessment of the continuing impact from international trade policy, together with various expected spending scenarios of key customers, supply chain constraints, and the timing of acceptances for first tools under evaluation in the field.” · word for word
29 May 20268-K · 8.01Disclosed a material event under other events (litigation, recall, contract loss, or major announcement); filed financial statements and exhibits with this reportopen
Risks flagged
Listing subject to regulatory approvals from CSRC, HKEX, and SFC; may not be completed.
“The proposed H Share Listing remains subject to market conditions and the obtaining of necessary filings, approvals and/or other regulatory clearances, including those from the China Securities Regulatory Commission, The Stock Exchange of Hong Kong Limited and the Securities and Futures Commission of Hong Kong.” · word for word
15 May 20268-K · 8.01Shares issued 2,884,615; Offering price per share $52.00; Net proceeds $150Mopen
Figures in the filing · each found in the filing text
| Shares issued · point_in_time | 2,884,615 | |
| Offering price per share · point_in_time | $52.00 | |
| Net proceeds · point_in_time | $150M |
Risks flagged
Share dilution
“2.88 million new shares issued”
12 May 20268-K · 1.01ACM Research, Inc. enters Securities Purchase Agreement for registered direct offering of 2,884,615 shares of Class A common stock at $52.00 per share, raising ~$149.85M net proceeds for U.S. and global expansion and general corporate purpoopen
Figures in the filing · each found in the filing text
| Shares offered · 2026-05-12 | 2,884,615 | |
| Offering price per share · 2026-05-12 | $52.00 | |
| Net proceeds · 2026-05-12 | $149849.98B |
Risks flagged
Dilution risk from new share issuance; lock-up agreement may limit near-term selling pressure.
“2,884,615 shares issued; 6-month lock-up with waiver possibility.”
8 May 202610-QRevenue $231M (+34% y/y); Net Income $26M (+5% y/y); Shipments $241M (+54% y/y)open
Figures in the filing · each found in the filing text
| Revenue · Q1-2026 | $231M | +34% y/y |
| Net Income · Q1-2026 | $26M | +5% y/y |
| Shipments · Q1-2026 | $241M | +54% y/y |
| Free Cash Flow · Q1-2026 | $-52M | -355% y/y |
| Operating Cash Flow · Q1-2026 | $-30M | -659% y/y |
7 May 20268-K · 2.02Revenue $231M (+34% y/y); Shipments $241M (+54% y/y); Gross margin (GAAP) 46.4; Guidance: FY2026 revenue $1.08B-$1.175B (21-30% growth)earningsopen
Figures in the filing · each found in the filing text
| Revenue · Q1-2026 | $231M | +34% y/y |
| Shipments · Q1-2026 | $241M | +54% y/y |
| Gross margin (GAAP) · Q1-2026 | 46.4% | |
| Income from operations (GAAP) · Q1-2026 | $36M | +40% y/y |
| Net income attributable to ACM Research, Inc. (GAAP) · Q1-2026 | $17M | -15% y/y |
| Diluted EPS (GAAP) · Q1-2026 | $0.24 | -20% y/y |
Guidance
FY2026 revenue $1.08B-$1.175B (21-30% growth)
Reaffirmed FY2026 revenue guidance; strong Q1 beat; new product cycles and global expansion support outlook.
Risks flagged
International trade policy and supply chain constraints could impact future revenue.
“Outlook depends on continuing impact from international trade policy, supply chain constraints.”
Timing of customer acceptances for first tools under evaluation may cause revenue volatility.
“Timing of acceptances for first tools under evaluation is a factor in outlook.” · word for word
27 Apr 20268-K · 2.02Guidance: FY2026 revenue $1.08B-$1.175B (20-30% growth)earningsopen
Guidance
FY2026 revenue $1.08B-$1.175B (20-30% growth)
Reaffirmed FY2026 revenue guidance; preliminary Q1 results above prior expectations.
Risks flagged
Preliminary results subject to completion of closing procedures and audit review.
“Actual unaudited first quarter 2026 results are subject to the completion of ACM’s quarter end closing procedures and review by ACM’s independent registered public accounting firm.” · word for word
17 Apr 20268-K · 8.01Disclosed a material event under other events (litigation, recall, contract loss, or major announcement); filed financial statements and exhibits with this reportopen
Risks flagged
H Share Listing may not be implemented; regulatory and market risks.
“Whether the H Share Listing will ultimately be implemented is uncertain.” · word for word
24 Mar 20268-K · 8.01Disclosed a material event under other events (litigation, recall, contract loss, or major announcement); filed financial statements and exhibits with this reportopen
Risks flagged
No material risk identified; dividend proposal is routine and subject to approval.
19 Mar 20268-K · 8.01Disclosed a material event under other events (litigation, recall, contract loss, or major announcement); filed financial statements and exhibits with this reportopen
Risks flagged
No material risk identified.
2 Mar 202610-KHeadcount growth 24open
Figures in the filing · each found in the filing text
| Headcount growth · FY2025 | 24.0% |
Risks flagged
Export Control Risk
“Effective on December 2, 2024, BIS promulgated a final rule naming a number of companies to the BIS Entity List Among the 140 companies added to the BIS Entity List were two subsidiaries of ACM Research, ACM Shanghai, located in the People’s Republic of China, and ACM Korea, a direct subsidiary of ACM Shanghai, which is located in the Republic of Korea, and ” · word for word
Supply Chain Concentration Risk
“We depend on a limited number of suppliers, including single source suppliers, for critical components and subassemblies, and our business could be disrupted if they are unable to meet our needs.” · word for word
Growth Management Risk
“our headcount grew by 24% in 2025, 27% in 2024, and 32% in 2023.” · word for word
26 Feb 20268-K · 2.02Revenue $901M (+15% y/y); Gross margin 44.4; Net income attributable to ACM Research, Inc. $94M (-9% y/y); Guidance: FY2026 revenue guidance $1.08B-$1.175B, representing 21-30% growthearningsopen
Figures in the filing · each found in the filing text
| Revenue · FY2025 | $901M | +15% y/y |
| Gross margin · FY2025 | 44.4% | |
| Net income attributable to ACM Research, Inc. · FY2025 | $94M | -9% y/y |
| Diluted EPS · FY2025 | $1.37 | -11% y/y |
| Shipments · FY2025 | $854M | -12% y/y |
| Net cash · FY2025 | $845M |
Guidance
FY2026 revenue guidance $1.08B-$1.175B, representing 21-30% growth
Maintained strong revenue guidance for FY2026, reflecting robust demand despite gross margin pressure from investments.
Risks flagged
Gross margin compression due to product mix and investments
“Gross margin declined from 50.1% to 44.4% GAAP in FY2025”
Dependence on China market and trade policy risks
“Guidance based on management's assessment of international trade policy impact”
Shipments declined 12.2% in FY2025, indicating potential demand timing issues
“Total shipments in 2025 were $854 million, down 12.2%” · word for word
6 Feb 20268-K · 8.01Disclosed a material event under other events (litigation, recall, contract loss, or major announcement); filed financial statements and exhibits with this reportopen
Risks flagged
Reduced ownership in ACM Shanghai may indicate strategic shift or need for capital.
“Ownership decreased from 74.84% to 73.72%.”
3 Feb 20268-K · 8.01Shares to be Sold 4,801,648; Transfer Price per Share 160open
Figures in the filing · each found in the filing text
| Shares to be Sold | 4,801,648 | |
| Transfer Price per Share | $160.00 |
Risks flagged
Uncertainty about completion and proceeds of share sale.
“These risks and uncertainties include the number of Shares the Company may sell under the Plan (if any), the prices at which such Shares may be sold, the aggregate proceeds to the Company from such sales, market conditions” · word for word
30 Jan 20268-K · 8.01Shares to be Sold 4,801,648; Ownership Percentage 1.34open
Figures in the filing · each found in the filing text
| Shares to be Sold | 4,801,648 | |
| Ownership Percentage | 1.3% |
Risks flagged
Uncertainty about completion and proceeds of share sale.
“These risks and uncertainties include the number of Shares the Company may sell under the Plan (if any), the prices at which such Shares may be sold, the aggregate proceeds to the Company from such sales, market conditions” · word for word
22 Jan 20268-K · 2.02Guidance: FY2025 revenue guidance raised to $885-$900M (from $875-$925M); FY2026 initial guidance $1,080-$1,175Mearningsopen
Guidance
FY2025 revenue guidance raised to $885-$900M (from $875-$925M); FY2026 initial guidance $1,080-$1,175M
ACM raised FY2025 revenue guidance and provided strong FY2026 outlook, driven by semiconductor equipment demand and market share gains.
Risks flagged
Guidance subject to risks from international trade policies, customer spending scenarios, supply chain constraints, and tool acceptance timing.
“This expectation is based on ACM management's current assessment of the impact from international trade policies, together with various expected spending scenarios of key customers, supply chain constraints, and the timing of acceptances for first tools under evaluation in the field.” · word for word
6 Nov 202510-QTotal Revenue $657M (+18% y/y); Shipments $626M (-12% y/y); Gross Margin 45.7open
Figures in the filing · each found in the filing text
| Total Revenue · 9M-2025 | $657M | +18% y/y |
| Shipments · 9M-2025 | $626M | -12% y/y |
| Gross Margin · 9M-2025 | 45.7% | |
| Net Income · 9M-2025 | $108M | +17% y/y |
| Adjusted EBITDA · 9M-2025 | $126M | -18% y/y |
| Free Cash Flow · 9M-2025 | $-87M | +446% y/y |
| Operating Cash Flow · 9M-2025 | $-44M | -169% y/y |
| EPS Diluted · 9M-2025 | $1.02 |
Risks flagged
Working Capital Drain
“Net changes in operating assets and liabilities ($174,950) driven by $80.7M inventory increase and $91.3M receivables increase.” · word for word
China Regulatory Risk
“Mainland China's currency exchange control and government restrictions on investment repatriation may impact our ability to transfer funds outside of mainland China.” · word for word
Debt Covenant Risk
“Loan covenants require ACM Shanghai to maintain year-end outstanding interest-bearing debt not to exceed five times annual EBITDA.”
5 Nov 20258-K · 2.02Revenue $269M (+32% y/y); Gross margin 42; Income from operations $29M (-34% y/y); Guidance: FY2025 revenue guidance narrowed to $875M-$925M from $850M-$950Mearningsopen
Figures in the filing · each found in the filing text
| Revenue · Q3-2025 | $269M | +32% y/y |
| Gross margin · Q3-2025 | 42.0% | |
| Income from operations · Q3-2025 | $29M | -35% y/y |
| Net income attributable to ACM Research, Inc. · Q3-2025 | $36M | +16% y/y |
| Diluted EPS · Q3-2025 | $0.52 | +16% y/y |
| Total shipments · Q3-2025 | $263M | +1% y/y |
| Revenue guidance (FY2025) · FY2025 | $900M |
Guidance
FY2025 revenue guidance narrowed to $875M-$925M from $850M-$950M
Revenue guidance raised and narrowed, reflecting strong demand but margin pressure from product mix and investments.
Risks flagged
Gross margin pressure from product mix and higher operating expenses.
“Gross margin declined to 42% from 51.4% YoY; operating expenses up 38.9%.”
International trade policy and supply chain constraints could impact future revenue.
“Guidance notes continuing impact from international trade policy and supply chain constraints.”
Dilution from ACM Shanghai capital raise reduces ACM's ownership to 74.6%.
“ACM's equity interest in ACM Shanghai declined from 81.1% to 74.6%.”
29 Oct 20258-K · 2.02Guidance: Revenue guidance raised to $264M-$267M for Q3 2025earningsopen
Guidance
Revenue guidance raised to $264M-$267M for Q3 2025
Preliminary Q3 2025 revenue guidance raised to $264M-$267M, representing 29%-31% YoY growth, indicating strong demand for semiconductor equipment.
Risks flagged
Dependence on ACM Shanghai for majority of revenue and net income, with accounting differences between RMB/Chinese GAAP and USD/US GAAP.
“ACM currently owns a 74.6% equity interest in ACM Shanghai, and a substantial majority of ACM’s consolidated revenue and net income is contributed by ACM Shanghai. The stand-alone financial results of ACM Shanghai are reported in RMB as prepared in accordance with Chinese generally accepted accounting principles, and those results will differ, potentially ma” · word for word
ACM Research, Inc. — questions
- What did ACM Research, Inc. file recently?
- 27 SEC filings in the last 12 months. Latest: 8-K on 2026-09-30 — ACM Research subsidiary provides backlog data via press release;
Every figure on this page comes from ACM Research, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.